Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01669317 · ClinicalTrials.gov registry record · NA

Mechanisms Underlying the Sleep Promoting Effect of Cherry Juice Standardized to Its Proanthocyanidin Content

A NA study, sponsored by Pennington Biomedical Research Center.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT01669317: Completed NA study, sponsored by Pennington Biomedical Research Center.

NCT01669317 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01669317, a NA study, has completed, sponsored by Pennington Biomedical Research Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This study is designed to demonstrate that cherry juice is effective in treating insomnia, and to show that it works by inhibiting an enzyme that will be measured in the blood.

Primary Outcome

Compare the polysomnography of participants with insomnia on a night at the end of 2 weeks taking: Eight ounces of standardized cherry juice vs. the night taking the placebo juice.

Interventions

  • OTHER 8-ounce glass of cherry juice
  • OTHER Artificial Cherry Juice

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-06
Est. Completion 2015-10
Phase NA

What the finished NCT01669317 record still lists

NCT01669317 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which 8-ounce glass of cherry juice is the first listed.

NCT01669317 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01669317 about?

NCT01669317 is a clinical study titled "Mechanisms Underlying the Sleep Promoting Effect of Cherry Juice Standardized to Its Proanthocyanidin Content". This study is designed to demonstrate that cherry juice is effective in treating insomnia, and to show that it works by inhibiting an enzyme that will be measured in the blood.

What is the current status of trial NCT01669317?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-06. Estimated completion is 2015-10.

What interventions are being tested in trial NCT01669317?

The interventions under investigation include: 8-ounce glass of cherry juice (OTHER), Artificial Cherry Juice (OTHER).

Who is sponsoring clinical trial NCT01669317?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01669317's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01669317, the US trial registry maintained by the National Library of Medicine. NCT01669317 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.